Discussion regarding the differences in levels of innate host defense proteins, specifically secretory leukocyte protease inhibitor (SLPI) and lipocalin-1, in the sputum of individuals with cystic fibrosis who experience frequent pulmonary exacerbations compared to those with infrequent exacerbations.